News and Press Releases

Novonesis expands global footprint with acquisition of production facility in Southeast Asia

Investment of around USD 50 million strengthens fermentation capabilities and supports the company’s long-term growth ambitions 8 April 2026 -- Copenhagen, Denmark -- Novonesis has signed an agreement with Meihua to...

Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: April 8, 2026

Biologiens Vej 2 2800 Lyngby Denmark

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology

Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organismsPatent now opens up significant potential for further commercial use through licensing BRAIN Biotech offers its technology for...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 23, 2026

Darmstädter Straße 34 – 36 64673 Zwingenberg Deutschland

Neuland to open commercial peptide facility as part of planned phased expansion

The CDMO’s Module 1 commercial production facility to be operational by summer 2026 9 March 2026 -- Hyderabad, India -- Neuland Laboratories  will open its new commercial peptide facility in the...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: March 9, 2026

11th Floor (5th Level), Phoenix IVY Building, Plot No. 573A-III, Road No. 82, Jubilee Hills, Hyderabad, 500033, Telangana, India.

Codexis signs agreement to manufacture 50g siRNA using its ECO Synthesis Manufacturing Platform

4 March 2026 -- California, US -- Codexis, Inc, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced it has entered into an agreement with...

Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: March 4, 2026

200 Penobscot Drive
 Redwood City, California 94063
 650-421-8100

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure

Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds Aurase shows dual action on chronic wound debridement and healing SolasCure preparing fund raising for...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 25, 2026

Darmstädter Straße 34 – 36 64673 Zwingenberg Deutschland

SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel

Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next phase of development Data...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 24, 2026

wellington house East Rd, Petersfield, Cambridge CB1 1BH

Moderna Receives MHRA Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

The LP.8.1 vaccine is the first commercially licenced mRNA vaccine to be manufactured in the UK at the Moderna Innovation and Technology Centre in Oxfordshire The updated vaccines will be...

Category: Biotechnology, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: February 10, 2026

Global Headquarters 200 Technology Square Cambridge, MA 02139

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression to phase 2 clinical trials in Malawi Demonstrates Recipharm’s agility and flexibility, completing full tech transfer, scale-up and process optimisation within three...

Category: BioManufacturing, Drug Delivery, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 15, 2025

PlasmidFactory founder Dr. Martin Schleef honored with the NRW Innovation Award 2025

8 September 2025 -- Düsseldorf/Bielefeld, Germany -- The founder and long-standing CEO of PlasmidFactory GmbH, Dr. Martin Schleef, was honored today in Düsseldorf with the Innovation Award 2025 of the...

Category: BioManufacturing, Other, Pharmaceutical
Posted: September 8, 2025

Meisenstraße 96, D-33607 Bielefeld, Germany

Sanner starts manufacturing in Greensboro, USA

18 June 2025 -- North Carolina, US -- Sanner has officially launched manufacturing operations in Greensboro, North Carolina. The new facility is dedicated to producing critical injection-molded components for medical...

Category: Logistics, Manufacturing and Packing, Other, Pharmaceutical, Pharmaceutical Contractors
Posted: June 18, 2025

Schillerstrasse 76 64625 Bensheim

CARBOGEN AMCIS Accelerates Manufacturing Capacity with CHF 25.5 Million Co-Investment at Swiss Sites

4 June 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce a strategic co-investment of more...

Category: Logistics, Manufacturing and Packing, Pharmaceutical
Posted: June 4, 2025

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

Novonesis probiotic strain receives health claim in Canada

Health Canada authorizes functional claims that the new probiotic strain CLEPIUS™ “helps alleviate perceived stress and improve irritable bowel syndrome-related quality of life in adults” 11 March 2024 -- Copenhagen,...

Category: Biotechnology, Other, Pharmaceutical
Posted: March 11, 2025

Biologiens Vej 2 2800 Lyngby Denmark

Micreos Pharmaceuticals partners with Biologics CDMO Northway Biotech for its Engineered Endolysin therapeutic manufacturing program

4 March 2025 -- Zug, Switzerland, and Vilnius, Lithuania -- Micreos Pharmaceuticals AG ("Micreos"), a preclinical-stage biopharmaceutical company, specializing in developing Engineered Endolysin therapies to target harmful pathogens that cause...

Category: BioManufacturing, Biotechnology, Other, Pharmaceutical
Posted: March 4, 2025

Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site

13 January 2025 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of a Swissmedic...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 13, 2025

Hauptstrasse 171 CH-4416 Bubendorf Switzerland

Tower Launches Customer Sustainability Hub with Practical Tools for Lower-Impact Pharmaceutical Cold Chain

3 October 2024 – Tower Cold Chain has launched a sustainability hub for customers, highlighting how its consultative, pragmatic approach to pharmaceutical cold chain requirements can help to minimise waste...

Category: Manufacturing and Packing
Posted: October 17, 2024

Unit A, Total Park, Station Road, Theale, Reading, Berkshire RG7 4PN, UK